Literature DB >> 34717896

Loss of Hepatic Transcription Factor EB Attenuates Alcohol-Associated Liver Carcinogenesis.

Xiaojuan Chao1, Shaogui Wang1, Madeline Hlobik1, Andrea Ballabio2, Hong-Min Ni1, Wen-Xing Ding3.   

Abstract

Alcohol is a well-known risk factor for hepatocellular carcinoma. Autophagy plays a dual role in liver cancer, as it suppresses tumor initiation and promotes tumor progression. Transcription factor EB (TFEB) is a master regulator of lysosomal biogenesis and autophagy, which is impaired in alcohol-related liver disease. However, the role of TFEB in alcohol-associated liver carcinogenesis is unknown. Liver-specific Tfeb knockout (KO) mice and their matched wild-type (WT) littermates were injected with the carcinogen diethylnitrosamine (DEN), followed by chronic ethanol feeding. The numbers of both total and larger tumors increased significantly in DEN-treated mice fed ethanol diet than in mice fed control diet. Although the number of tumors was not different between WT and L-Tfeb KO mice fed either control or ethanol diet, the number of larger tumors was less in L-Tfeb KO mice than in WT mice. No differences were observed in liver injury, steatosis, inflammation, ductular reaction, fibrosis, and tumor cell proliferation in DEN-treated mice fed ethanol. However, the levels of glypican 3, a marker of malignant hepatocellular carcinoma, markedly decreased in DEN-treated L-Tfeb KO mice fed ethanol in comparison to the WT mice. These findings indicate that chronic ethanol feeding promotes DEN-initiated liver tumor development, which is attenuated by genetic deletion of hepatic TFEB.
Copyright © 2022 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34717896      PMCID: PMC8747011          DOI: 10.1016/j.ajpath.2021.10.004

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  59 in total

1.  Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis.

Authors:  Elizabeth Brandon-Warner; Tracy L Walling; Laura W Schrum; Iain H McKillop
Journal:  Alcohol Clin Exp Res       Date:  2011-10-21       Impact factor: 3.455

Review 2.  Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.

Authors:  Eric C Kauffman; Christopher J Ricketts; Soroush Rais-Bahrami; Youfeng Yang; Maria J Merino; Donald P Bottaro; Ramaprasad Srinivasan; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2014-07-22       Impact factor: 14.432

Review 3.  New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases.

Authors:  Jessica A Williams; Sharon Manley; Wen-Xing Ding
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 4.  Hepatitis C virus and autophagy.

Authors:  Linya Wang; Jing-hsiung James Ou
Journal:  Biol Chem       Date:  2015-11       Impact factor: 3.915

5.  MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells.

Authors:  Diego Ploper; Vincent F Taelman; Lidia Robert; Brian S Perez; Björn Titz; Hsiao-Wang Chen; Thomas G Graeber; Erika von Euw; Antoni Ribas; Edward M De Robertis
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

Review 6.  TFEB at a glance.

Authors:  Gennaro Napolitano; Andrea Ballabio
Journal:  J Cell Sci       Date:  2016-06-01       Impact factor: 5.285

Review 7.  Therapeutic targets in liver fibrosis.

Authors:  Jonathan A Fallowfield
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-13       Impact factor: 4.052

8.  TFEB regulates murine liver cell fate during development and regeneration.

Authors:  Nunzia Pastore; Tuong Huynh; Niculin J Herz; Alessia Calcagni'; Tiemo J Klisch; Lorenzo Brunetti; Kangho Ho Kim; Marco De Giorgi; Ayrea Hurley; Annamaria Carissimo; Margherita Mutarelli; Niya Aleksieva; Luca D'Orsi; William R Lagor; David D Moore; Carmine Settembre; Milton J Finegold; Stuart J Forbes; Andrea Ballabio
Journal:  Nat Commun       Date:  2020-05-18       Impact factor: 14.919

9.  TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins.

Authors:  Samrat T Kundu; Caitlin L Grzeskowiak; Jared J Fradette; Laura A Gibson; Leticia B Rodriguez; Chad J Creighton; Kenneth L Scott; Don L Gibbons
Journal:  Nat Commun       Date:  2018-07-16       Impact factor: 14.919

View more
  4 in total

1.  Recent insights into the pathogeneses and therapeutic targets of liver diseases: Summary of the 4th Chinese American Liver Society/Society of Chinese Bioscientists in America Hepatology Division Symposium in 2021.

Authors:  Wen-Xing Ding; Hua Wang; Yuxia Zhang
Journal:  Liver Res       Date:  2022-01-29

Review 2.  Role of mechanistic target of rapamycin in autophagy and alcohol-associated liver disease.

Authors:  Xiaojuan Chao; Sha Neisha Williams; Wen-Xing Ding
Journal:  Am J Physiol Cell Physiol       Date:  2022-09-05       Impact factor: 5.282

Review 3.  Role of TFEB in Autophagy and the Pathogenesis of Liver Diseases.

Authors:  Shengmin Yan
Journal:  Biomolecules       Date:  2022-05-06

4.  Impact of alcohol consumption on treatment outcome of hepatocellular carcinoma patients with viral hepatitis who underwent transarterial chemoembolization.

Authors:  Attapon Rattanasupar; Arunchai Chang; Tanaporn Prateepchaiboon; Nuttanit Pungpipattrakul; Keerati Akarapatima; Apiradee Songjamrat; Songklod Pakdeejit; Varayu Prachayakul; Teerha Piratvisuth
Journal:  World J Hepatol       Date:  2022-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.